Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 34596 | 109 | 36.7 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
| 275 | 3 | NSAIDS//CYCLOOXYGENASE//CYCLOOXYGENASE 2 | 43399 |
| 2305 | 2 | CYCLOOXYGENASE 2//COX 2//CELECOXIB | 4519 |
| 34596 | 1 | CYCLOOXYGENASE 1 INHIBITOR//ANTIOXIDANT DEFENSE MECHANISM//BIOMED NETWORK HEPAT DIGEST DIS | 109 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | CYCLOOXYGENASE 1 INHIBITOR | authKW | 560286 | 2% | 100% | 2 |
| 2 | ANTIOXIDANT DEFENSE MECHANISM | authKW | 373523 | 2% | 67% | 2 |
| 3 | BIOMED NETWORK HEPAT DIGEST DIS | address | 280143 | 1% | 100% | 1 |
| 4 | C MYC TGF ALPHA MODEL | authKW | 280143 | 1% | 100% | 1 |
| 5 | CONSEJO SUPER INVEST CIENT FARM | address | 280143 | 1% | 100% | 1 |
| 6 | CYCLOOXYGENASE 2 MEDIATED INFLAMMATION | authKW | 280143 | 1% | 100% | 1 |
| 7 | CYCLOXEGENASE 2 | authKW | 280143 | 1% | 100% | 1 |
| 8 | D ALPHA TOCOPHEROL ACETATE | authKW | 280143 | 1% | 100% | 1 |
| 9 | DIMINISHED LDL OXIDATION | authKW | 280143 | 1% | 100% | 1 |
| 10 | FIBROTIC FACTORS | authKW | 280143 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Gastroenterology & Hepatology | 510 | 21% | 0% | 23 |
| 2 | Toxicology | 156 | 12% | 0% | 13 |
| 3 | Pharmacology & Pharmacy | 144 | 23% | 0% | 25 |
| 4 | Veterinary Sciences | 89 | 11% | 0% | 12 |
| 5 | Cell Biology | 35 | 11% | 0% | 12 |
| 6 | Peripheral Vascular Diseases | 29 | 6% | 0% | 6 |
| 7 | Biochemistry & Molecular Biology | 24 | 17% | 0% | 18 |
| 8 | Endocrinology & Metabolism | 20 | 6% | 0% | 7 |
| 9 | Biophysics | 16 | 6% | 0% | 6 |
| 10 | Medicine, Research & Experimental | 15 | 6% | 0% | 6 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | BIOMED NETWORK HEPAT DIGEST DIS | 280143 | 1% | 100% | 1 |
| 2 | CONSEJO SUPER INVEST CIENT FARM | 280143 | 1% | 100% | 1 |
| 3 | HOUSE SMALL ANIM CLIN | 280143 | 1% | 100% | 1 |
| 4 | INVEST BIOMED ALBERO SOLS | 280143 | 1% | 100% | 1 |
| 5 | INVEST BIOMED IIB ALBERTO SOLS | 280143 | 1% | 100% | 1 |
| 6 | MED LEGAL ADM | 280143 | 1% | 100% | 1 |
| 7 | MED UNIV CLIN EPIDEMIOL | 280143 | 1% | 100% | 1 |
| 8 | PATHOL MOL CELLULAR THER Y | 280143 | 1% | 100% | 1 |
| 9 | PEDIAT SURGSEVERANCE CHILDRENS HOSP | 280143 | 1% | 100% | 1 |
| 10 | W NALT MED | 280143 | 1% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ONCOGENESIS | 1063 | 1% | 0% | 1 |
| 2 | LIVER INTERNATIONAL | 990 | 3% | 0% | 3 |
| 3 | GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM | 975 | 3% | 0% | 3 |
| 4 | DRUG AND CHEMICAL TOXICOLOGY | 832 | 2% | 0% | 2 |
| 5 | RESEARCH IN VETERINARY SCIENCE | 783 | 4% | 0% | 4 |
| 6 | SAUDI JOURNAL OF GASTROENTEROLOGY | 768 | 1% | 0% | 1 |
| 7 | BOLETIN LATINOAMERICANO Y DEL CARIBE DE PLANTAS MEDICINALES Y AROMATICAS | 603 | 1% | 0% | 1 |
| 8 | METABOLIC SYNDROME AND RELATED DISORDERS | 460 | 1% | 0% | 1 |
| 9 | HEPATOLOGY INTERNATIONAL | 430 | 1% | 0% | 1 |
| 10 | HEPATOLOGY RESEARCH | 418 | 2% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | IZQUIERDO, CL , MAYORAL, R , FLORES, JM , GARCIA-PALENCIA, P , CUCARELLA, C , BOSCA, L , CASADO, M , MARTIN-SANZ, P , (2011) TRANSGENIC MICE EXPRESSING CYCLOOXYGENASE-2 IN HEPATOCYTES REVEAL A MINOR CONTRIBUTION OF THIS ENZYME TO CHEMICAL HEPATOCARCINOGENESIS.AMERICAN JOURNAL OF PATHOLOGY. VOL. 178. ISSUE 3. P. 1361 -1373 | 13 | 30% | 3 |
| 2 | FRANCES, DE , MOTINO, O , AGRA, N , GONZALEZ-RODRIGUEZ, A , FERNANDEZ-ALVAREZ, A , CUCARELLA, C , MAYORAL, R , CASTRO-SANCHEZ, L , GARCIA-CASARRUBIOS, E , BOSCA, L , ET AL (2015) HEPATIC CYCLOOXYGENASE-2 EXPRESSION PROTECTS AGAINST DIET-INDUCED STEATOSIS, OBESITY, AND INSULIN RESISTANCE.DIABETES. VOL. 64. ISSUE 5. P. 1522 -1531 | 10 | 32% | 2 |
| 3 | MOTINO, O , FRANCES, DE , MAYORAL, R , CASTRO-SANCHEZ, L , FERNANDEZ-VELASCO, M , BOSCA, L , GARCIA-MONZON, C , BREA, R , CASADO, M , AGRA, N , ET AL (2015) REGULATION OF MICRORNA 183 BY CYCLOOXYGENASE 2 IN LIVER IS DEAD-BOX HELICASE P68 (DDX5) DEPENDENT: ROLE IN INSULIN SIGNALING.MOLECULAR AND CELLULAR BIOLOGY. VOL. 35. ISSUE 14. P. 2554 -2567 | 11 | 22% | 2 |
| 4 | CHANG, HK , CHANG, EY , RYU, S , HAN, SJ , (2016) CYCLOOXYGENASE-2 INHIBITOR REDUCES HEPATIC STIFFNESS IN PEDIATRIC CHRONIC LIVER DISEASE PATIENTS FOLLOWING KASAI PORTOENTEROSTOMY.YONSEI MEDICAL JOURNAL. VOL. 57. ISSUE 4. P. 893 -899 | 9 | 27% | 0 |
| 5 | EKOR, M , ODEWABI, AO , KALE, OE , ADESANOYE, OA , BAMIDELE, TO , (2013) CELECOXIB, A SELECTIVE CYCLOOXYGENASE-2 INHIBITOR, LOWERS PLASMA CHOLESTEROL AND ATTENUATES HEPATIC LIPID PEROXIDATION DURING CARBON-TETRACHLORIDE-ASSOCIATED HEPATOTOXICITY IN RATS.DRUG AND CHEMICAL TOXICOLOGY. VOL. 36. ISSUE 1. P. 1-8 | 11 | 21% | 5 |
| 6 | MOTINO, O , AGRA, N , CONTRERAS, RB , DOMINGUEZ-MORENO, M , GARCIA-MONZON, C , VARGAS-CASTRILLON, J , CARNOVALE, CE , BOSCA, L , CASADO, M , MAYORAL, R , ET AL (2016) CYCLOOXYGENASE-2 EXPRESSION IN HEPATOCYTES ATTENUATES NON-ALCOHOLIC STEATOHEPATITIS AND LIVER FIBROSIS IN MICE.BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE. VOL. 1862. ISSUE 9. P. 1710 -1723 | 11 | 20% | 0 |
| 7 | TAUSEEF, M , SHARMA, KK , FAHIM, M , (2007) ASPIRIN RESTORES NORMAL BAROREFLEX FUNCTION IN HYPERCHOLESTEROLEMIC RATS BY ITS ANTIOXIDATIVE ACTION.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 556. ISSUE 1-3. P. 136-143 | 8 | 28% | 20 |
| 8 | TAUSEEF, M , SHAHID, M , SHARMA, KK , FAHIM, M , (2008) ANTIOXIDATIVE ACTION OF ASPIRIN ON ENDOTHELIAL FUNCTION IN HYPERCHOLESTEROLAEMIC RATS.BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. VOL. 103. ISSUE 4. P. 314 -321 | 8 | 22% | 10 |
| 9 | YU, J , WU, CW , CHU, ESH , HUI, AY , CHENG, ASL , GO, MYY , CHING, AKK , CHUI, YL , CHAN, HLY , SUNG, JJY , (2008) ELUCIDATION OF THE ROLE OF COX-2 IN LIVER FIBROGENESIS USING TRANSGENIC MICE.BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. VOL. 372. ISSUE 4. P. 571-577 | 6 | 29% | 17 |
| 10 | BANDE, R , KAPOOR, S , GUPTA, S , (2014) NONSELECTIVE INHIBITION OF PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES BY NAPROXEN AMELIORATES ACUTE OR CHRONIC LIVER INJURY IN ANIMALS.EXPERIMENTAL AND MOLECULAR PATHOLOGY. VOL. 96. ISSUE 1. P. 27-35 | 7 | 22% | 0 |
Classes with closest relation at Level 1 |